X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of ($0.33), $0.17 worse than the analyst estimate of ($0.16). Revenue for the quarter came in at $-55.7 million.

For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.